FDA Issues Warning Letter to Zoll Medical Over Quality System Violations
The agency cites failures in corrective actions, design validation, and reporting for ventilators, defibrillators, and sensors.
The agency cites failures in corrective actions, design validation, and reporting for ventilators, defibrillators, and sensors.
The new defibrillators offer comprehensive diagnosis and monitoring tools, and introduce a whole-process quality improvement solution, according to Mindray.
Kestra Medical Technologies’ ASSURE WCD system is effective at reducing false-positive shock alarms, according to clinical evaluation results.
The agency cites failures in corrective actions, design validation, and reporting for ventilators, defibrillators, and sensors.
Kirkland, Wash.-based KestraMedical Technologies, Inc., announces that it has received U.S. FDA Premarket Approval for the ASSURE wearable cardioverter defibrillator system, which monitors and treats patients at risk of sudden cardiac death.
Read MoreThe government alleges that St. Jude failed to disclose serious adverse health events in connection with the premature depletion of the battery in certain models of its implantable defibrillators.
Read MorePlacing an iPhone 12 or its magnet-containing MagSafe accessories near a pacemaker can interfere with the medical device’s ability to function.
Read MoreFDA has changed the deadline for filing PMA applications for previously cleared AED accessories in response to the impact from COVID-19.
Read MoreA formalized protocol to transfer AED data upon hospital arrival for cardiac arrest patients may help staff decision-making and lessen the strain on hospital resources.
Read MoreRoyal Philips has launched a wireless remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the United States.
Read MorePhilips has resumed the manufacturing and shipping of external defibrillators for the United States, following FDA notification that the injunction prohibiting those activities has been lifted.